参考文献/References:
[1] 吕亚兰,刘聪,周文正,等. 新型冠状病毒肺炎与SARS和MERS的流行病学特征及其防控措施[J].医药导报,2020,39(3):334-337.
[2] 王玉波,何勇. 新型冠状病毒肺炎刍识[J].重庆医学,2020,49(15):2432-2434.
[3] 张梅,李闯. 新型冠状病毒肺炎与心血管疾病[J]. 武警医学,2020, 31(2):93-96.
[4] 郭栋,郭万刚,刘鹏云,等. 新型冠状病毒感染的心脏表现[J]. 心脏杂志,2020, 32(1):75-74 .
[5] 陈文浩,张焕基,郭攸胜,等. 活检证实病毒性心肌炎的治疗策略及预后[J]. 心血管病学进展,2019,40(5):813-817.
[6] 苗青,丛晓东,王冰,等. 新型冠状病毒感染的肺炎的中医认识与思考[J]. 中医杂志,2020, 61(4):286-288 .
[7] 高树明,马英,杨丰文,等. 张伯礼:中医药在防治新型冠状病毒肺炎全过程发挥作用[J].天津中医药,2020, 37(2):121-124 .
[8] 金信垚,刘强. 中医药治疗病毒性心肌炎的研究进展[J]. 中国中医急症, 2019,28(11):2050-2053.
[9] 陈亚文,张曼,刘志军. 苦参对病毒性心肌炎的作用综述[J]. 临床医药文献电子杂志,2018,5(42):190-192.
[10] Feng P,Che Y,Chen DQ. Molecular mechanism of action of liuwei dihuang pill for the treatment of osteoporosis based on network pharmacology and molecular docking[J]. Eur J Integr Med,2020,33:101009.
[11] Ru J,Li P,Wang J,et al. TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6(1):13.
[12] Bettelli E,Oukka M,Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity[J]. Nat Immunol,2007,8(4):345-350.
[13] Rabiei N,Badi SA,Marvasti FE,et al. Induction effects of faecalibacterium prausnitzii and its extracellular vesicles on toll-like receptor signaling pathway gene expression and cytokine level in human intestinal epithelial cells[J]. Cytokine,2019,121:154718.
[14] Hu Z,Li H,Xie R,et al. Genomic variant in porcine TNFRSF1A gene and its effects on TNF signaling pathway in vitro[J]. Gene,2019,700:105-109.
[15] Sonja T. NF-κB-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction[J]. Int J Cancer,2011,128(5):1104-1113.
[16] Guo X,Dong Z,Yamada S,et al. Association of Casp3 microRNA target site (1049216) SNP with the risk and progress of cervical squamous cell carcinoma[J]. Int J Gynecol Cancer,2017,27(2):206-213.
[17] Garakani K,Shams H,Mofrad MRK. Mechanosensitive conformation of vinculin regulates its binding to MAPK1[J]. Biophys J,2017,112(9):1885-1893.
相似文献/References:
[1]谭斯露 何胜虎.新型冠状病毒与SARS病毒的相似性及对心脏的影响[J].心血管病学进展,2020,(9):947.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.015]
TAN Silu,HE Shenghu.Similarity of Novel Coronavirus and SARS Virus and Their Effects on Heart[J].Advances in Cardiovascular Diseases,2020,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.015]
[2]张艺文 蔡琳 秦莉 杨晓倩 汪汉.基于网络药理学的参麦注射液治疗新型冠状病毒感染合并心肌炎的机制研究[J].心血管病学进展,2020,(10):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
ZHANG YiwenCAI LinQIN LiYANG XiaoqianWANG Han.Shenmai Injection for COVID-19 with Myocarditis Based on Network Pharmacology[J].Advances in Cardiovascular Diseases,2020,(6):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
[3]汪汉,刘汉雄,蔡琳.2019冠状病毒病的心血管表现[J].心血管病学进展,2020,(11):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
WANG Han,LIU Hanxiong,CAI Lin.Cardiovascular Profiles in Corona V irus Disease 2019[J].Advances in Cardiovascular Diseases,2020,(6):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]